Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Coulda, woulda, shoulda...
I'm still holding for the long-term, but I have to admit that I am a bit peeved about the CUSIP change back in Dec. The whole shares on lock down sucked. I could have sold at the high and buy back more shares at a lower price, but nope...was still locked even when it began to drop. Coulda, woulda, shoulda.
Company's fundamentals have not changed. Looking forward to the updates, specifically with the spin-off. He did say that he will address how this will benefit shareholders.
Holding long still.
What's the definitive materials filing for? I don't see AMBS in the Lateef Fund portfolio...then again, their latest portfolio update was 12/31/2012. So maybe they added us recently???
Anyone???
@vgmiller3, thanks. I saw that you had put the bloomberg article as well. Great news for biotechs and patients if this shorter FDA approval process happens. AMBS would slingshot forward for sure.
AMBS
MANF potential worth a lot. AMBS can prove it.
Small taps to bring it down. Slap the ask folks.
I think my L2 needs MANF. I'm seeing .0855 on the bid and 0.084 on the ask.
"The scientific community and the FDA believe that it is critical to identify and study patients with very early Alzheimer's disease before there is too much irreversible injury to the brain," said Dr. Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research.
Read more on FDA guidance outline:
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338287.pdf
Amarantus Diagnostics to hit its milestones in 2013, expects to generate revenue.
Investment Opportunity!
And you bought those shares too!
She's moving fast.
AOM, good stuff.
Enjoying a slice of sernik with coffee before I continue my AMBS investigative research. It's 36 degrees and cloudy in Boulder, CO. New York temperature not much difference -- 35 degrees and sunny. I hope the weather lightens up for tomorrow's conference.
Well if you ask me, the MJFox Foundation hands out grants on a schedule. IMO, AMBS was a little too excited with their groundbreaking test results & jumped the gun with the PR mentioning another MJFox Foundation grant. Again, if you read up on the MJFox Foundation grant application/award details, you will see that they offer it during certain a timeframe pending data/study results. As a result, AMBS had to make a correction to their statement.
Patience grasshoppers.
<<AMBS>> HUGE HERE!!
Starting point for due diligence can be found here:
https://docs.google.com/document/d/1V10erwVdBvy6Um35Ay8XV0wV3TAPr6oME2fJG_jFvl4/mobilebasic?pli=1
Courtesy of SBA
I appreciate the posts by Series of Dreams. Although not so common, it sparks common sense in the minds of smart investors to actually perform their due diligence before investing. Reading and researching facts is the way to go rather than making a decision based on what you read on a message board.
I've done my DD, now do yours. Go AMBS!
Like bargain shopping? Scoop 'em up! Sale won't last long.
Distraught shareholders down 60%?? What'chu talkin' 'bout, Willis?
Who is down 60%?
2012 4th Quarter report expected soon. Last 10-Q does not reflect everything that happened in the last 3 months.
You can lead a horse to water, but you can't make it drink.
DD courtesy of SBA:
https://docs.google.com/document/d/1V10erwVdBvy6Um35Ay8XV0wV3TAPr6oME2fJG_jFvl4/mobilebasic?pli=1
REAL AMBS info:
http://ir.stockpr.com/amarantus/company-news
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001424812&owner=exclude&count=40
MANF is REAL, and Amarantus owns the IP for these therapeutic proteins.
MANF:
http://www.jbc.org/content/early/2012/12/19/jbc.M112.400648.short
https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=644
http://www.ncbi.nlm.nih.gov/pubmed/12794311
Heck, even Arrayit mentions MANF!
"Parkinson’s Disease Bioinformatics
Arrayit analyzed 31,500,000 H25K gene expression data points from 18 patients with Parkinson’s Disease using Arrayit Genome Pathway Builder™ (GPB) software, which utilized multivariate calculus, fuzzy logic and artificial intelligence to construct a biological pathway for Parkinson’s Disease. Biological pathway construction was helpful because it provided a molecular basis for PD and will allow a targeted approach to the discovery and testing of therapeutic proteins and drugs including mesencephalic astrocyte-derived neurotrophic factor (MANF).
Parkinson’s Disease Biological Pathway
Arrayit bioinformatic analysis of 18 Parkinson’s patients using Genome Pathway Builder™ (GPB) software allowed us to construct a best-fit biological pathway for Parkinson’s Disease. The modeled pathway responsible for PD symptoms appears to involve a cellular malfunction in the pathway that mediates protein folding, misfolding and removal inside human cells. This model is provocative because it is consistent with the neuropathology observed in Parkinson’s patients whereby accumulated protein aggregates disrupt the function of the dopaminergic cells comprising the substantia nigra. The promising protein therapeutic lead compound mesencephalic astrocyte-derived neurotrophic factor (MANF) appears to work by exerting its mode of action on the same biological pathway."
source: http://www.arrayit.com/Microarray_Diagnostics/Parkinsons_Disease/parkinsons_disease.html
What's good, ERBB?
Awaiting release of latest 10-Q by end of month or early March. This should clear up a bunch of foul cries.
Smart investors are patient investors. Know what you own.
"Doing your proper DD will prevent yourself from being scammed out of selling your shares for less than they are worth, or buying shares that are overvalued. Do not trust what others say, you must check every fact and pull them straight from SEC filings, not message boards. I hope all investors take the time to read the 10qs, and 8ks for not only AMBS, but all their future investments as well. This google doc will get you started nicely, but still only scrapes the surface of outlining AMBS’ true potential. Check every fact in this as well, for I am a human just like you and am subject to certain biases and misinterpretations."
Quote taken from here, courtesy of lewsogge, aewilliamson, SBA:
https://docs.google.com/document/d/1V10erwVdBvy6Um35Ay8XV0wV3TAPr6oME2fJG_jFvl4/mobilebasic?pli=1
Know what you own
From Feb. 4, 2013 PR:
http://ir.stockpr.com/amarantus/company-news/detail/553
"The Company has retained a Swiss neuroscience-focused consulting firm to conduct a full audit of the data derived from these experiments and assist the Company in planning for its IND package. The Company will be reporting additional rodent data in the first quarter on a 6-OHDA neuroprotection rat model of Parkinson's disease where both MANF and GDNF were delivered to the substantia nigra. The final report for all rodent experiments will be made public in the second quarter following completion of the data audit."
Swiss neuroscience-focused consulting firm...I speculate that Roche may have its hands on this.
Scoop 'em up folks. You know the dance.
AMBS
Gee whiz, all I implied was that the AMBS chart signals BUY.
No real selling here. Shares are being accumulated.
A lot of positive things happened since the last 10Q, smart investors know this. Strong upside to owning stock. Do your DD and everything will be fine. Know what you own.
Latest 10Q is already dated. Expect new 10Q soon with updated info. Check the calendar, it's February!
Lots of accumulation, no one is selling. Smart investors holding shares. Buying more on the dips.
AMBSis a VERY SMART overnight hold, especially if you know what you own.
Nice find Lew!
Buyer BEWARE. SERIES OF DREAMS is a LIAR willing to SAY ANYTHING to steal your shares in this REAL company.
Interestingly, all 3 highlighted are actively traded on the Berlin Market.
I'm guesstimating that the reconfirmation of the "too good to be true" MANF tests results will be available by late February. That's 6 weeks give or take from when Dr. John received the test results the night before his OneMed Forum presentation.
Testing timeframe per slide info is 6 weeks.
HUGE HERE!
Closed, MLK Holiday